The Cutting Edge of Medical Technology Content, Community & Collaboration
2010 Year End Wrap-Up ... BIO (Biotechnology Industry Organization ) President
Colleagues,
A message on the state of biotechnology in the U.S. from BIO President, James Greenwood ...
Looking back at 2009 -- Biotech industry weathers the economic storm
James C. Greenwood, BIO president and CEO
The economic recession has had a tremendous impact on the biotechnology industry this year. Biotech innovators with promising research continue to have difficulty securing investment funds, forcing layoffs, curtailed projects and company closures. Thankfully, policymakers who recognize the value of biotechnology have proposed steps to help the industry emerge.
The Therapeutic Project Tax Credit would help pioneering, research-intensive small businesses continue their cutting-edge projects.
In health care legislation, a bipartisan majority of key committees in both the House and Senate supported an approval pathway for biosimilars that will strike the critical balance among promoting patient safety, expanding access, lowering costs and promoting continued innovation. A number of governors and patient, physician and academic groups joined BIO in supporting this critical legislative language.
In formulating rules for the Renewable Fuel Standard, EPA recognized the contributions biotechnology makes to low-carbon biofuel production, finding that biofuels can significantly reduce transportation emissions compared to gasoline.
And finally, the Obama administration recognized the contributions biotechnology can make to feeding the world as it launched a new global food security initiative. We know that science and technology are already providing solutions to the 12.3 million farmers using agricultural biotechnology today in developing countries. In the future, biotech will be able to enhance the nutritional content of foods and improve human health through plant- and animal-produced therapies
--------------------------------------------------------------------------------------------
ENJOY!
CC
A message on the state of biotechnology in the U.S. from BIO President, James Greenwood ...
Looking back at 2009 -- Biotech industry weathers the economic storm
James C. Greenwood, BIO president and CEO
The economic recession has had a tremendous impact on the biotechnology industry this year. Biotech innovators with promising research continue to have difficulty securing investment funds, forcing layoffs, curtailed projects and company closures. Thankfully, policymakers who recognize the value of biotechnology have proposed steps to help the industry emerge.
The Therapeutic Project Tax Credit would help pioneering, research-intensive small businesses continue their cutting-edge projects.
In health care legislation, a bipartisan majority of key committees in both the House and Senate supported an approval pathway for biosimilars that will strike the critical balance among promoting patient safety, expanding access, lowering costs and promoting continued innovation. A number of governors and patient, physician and academic groups joined BIO in supporting this critical legislative language.
In formulating rules for the Renewable Fuel Standard, EPA recognized the contributions biotechnology makes to low-carbon biofuel production, finding that biofuels can significantly reduce transportation emissions compared to gasoline.
And finally, the Obama administration recognized the contributions biotechnology can make to feeding the world as it launched a new global food security initiative. We know that science and technology are already providing solutions to the 12.3 million farmers using agricultural biotechnology today in developing countries. In the future, biotech will be able to enhance the nutritional content of foods and improve human health through plant- and animal-produced therapies
--------------------------------------------------------------------------------------------
ENJOY!
CC
Views: 7
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
